Pfizer-Lilly Pain Drug Meets Late-Stage Trial Goals

(Reuters)—An experimental osteoarthritis drug developed by Pfizer Inc and Eli Lilly and Co achieved its main goal of lowering pain in a late stage trial, the companies said on Wednesday, potentially offering a safer alternative to opioids. Opioid abuse has reached epidemic proportions in the United States and drugmakers have been looking for less addictive... [Read More]
Source: The Rheumatologist - Category: Rheumatology Authors: Tags: Drug Updates Osteoarthritis Eli Lilly and Co experimental osteoarthritis drug Opioid abuse opioid epidemic Pfizer Inc. safer alternative to opioids tanezumab Source Type: research